With the annual Medicare Advantage (MA) open enrollment well underway (October 15th – December 7th each year), it’s the perfect time to revisit the significant changes outlined in the Centers for Medicare & Medicaid Services (CMS) 2024 Medicare Advantage and Part D Final Rule (CMS-4201-F).1 With a strong emphasis on equity and access to healthcare, these adjustments aim to protect beneficiaries, strengthen quality measures, and advance health equity for all Medicare recipients.
In this two-part blog post, we’ll explore the key provisions of the final rule and their implications for healthcare payers.
To ensure that beneficiaries have timely access and continuity of care, the CMS final rule includes various utilization management (UM) requirements changes. These changes include requiring:
These changes could create challenges for payers, as they may need to invest in new technologies and services, such as clinical decision support systems and automated prior authorization systems, to comply with the new UM requirements and improve the timeliness of care for their enrollees.
In addition to investing in new technology, payers can mitigate the challenges of the new UM requirements by communicating with providers and monitoring and evaluating their performance. By working with providers to understand the new requirements and tracking how long it takes to get prior authorization approvals, payers can identify and address any areas of improvement.
The CMS final rule includes changes to marketing requirements to protect beneficiaries from misleading or confusing information and ensure they can make informed decisions about their coverage. These changes include:
These new marketing requirements could make it more difficult for payers to reach potential enrollees. Payers may need to revise their marketing materials and strategies to comply with the new requirements. They may also need to invest in new training for their marketing staff.
In pursuit of elevated quality standards and greater equity, the Medicare Star Rating Program updates encompass:
These new Star Rating Program changes could make it more difficult for payers to achieve high Star Ratings. However, they will also help ensure that plans focus on the most important quality measures. Payers may need to adjust their quality improvement strategies to comply with the new Star Rating Program requirements. They may also need to invest in new data collection and analysis capabilities to track their performance on the new measures.
To ensure that all beneficiaries have access to high-quality care, MA and Part D programs are required to implement changes to advance health equity. These modifications include:
The new health equity requirements will significantly impact payers, affecting costs, operations, and staffing levels, and aid in payer-provider collaborations. Compliance may necessitate investment in digital health education, cultural competency training for providers, provider directories, and new data collection/reporting systems to track social risk factors and health outcomes. Payers must also update quality improvement programs to address care disparities, potentially requiring the development of new interventions and progress tracking.
Stay tuned for part two, where we will continue to look at key provisions in the CMS final rule and how they will impact payers. Together, we can navigate these changes and delivering the care that Medicare beneficiaries deserve. All while upholding the standards of affordability and quality in healthcare services.
Schedule a discovery call today to learn how HealthAxis can help you transform your health plan operations with our cutting-edge CAPS technology, modern BPaaS/BPO capabilities, and industry expertise.
Source:
1. Fact sheet 2024 Medicare Advantage and Part D Final Rule (CMS-4201-F), CMS